Needham on Hims and Hers (HIMS): 'we believe this incremental near-term investment and likely growing pains'

Go back to Needham on Hims and Hers (HIMS): 'we believe this incremental near-term investment and likely growing pains'

Hims & Hers Health, Inc. Reports Third Quarter 2025 Financial Results

November 3, 2025 4:05 PM EST

Revenue of nearly $600 million, up 49% year-over-year in Q3 2025

Net income of nearly $16 million; Adjusted EBITDA of over $78 million in Q3 2025

Subscribers grew to almost 2.5 million, up 21% year-over-year in Q3 2025

Narrows full year 2025 revenue guidance to $2.335 billion to $2.355 billion and Adjusted EBITDA guidance to $307 million to $317 million

SAN FRANCISCO--(BUSINESS WIRE)-- Hims & Hers Health, Inc. (Hims & Hers or the Company, NYSE: HIMS), the leading health and wellness platform, today announced financial results for the third quarter... More